SCHEMBL24468878

SCHEMBL24468878

CSCN[C@H](CCC(=O)C(C)C)C(=O)C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25773839 0.80 MMP3 (0.32) —
SCHEMBL21029776 0.79 — —
SCHEMBL21297373 0.76 KDM4E (0.32) —
SCHEMBL22844805 0.74 — —
SCHEMBL278867 0.74 — —
SCHEMBL23685458 0.73 ALDH1A1 (0.41) —
SCHEMBL10308346 0.73 ALDH1A1 (0.41) —
SCHEMBL25448139 0.72 CTSC (0.34) —
SCHEMBL18513225 0.72 NOD1 (0.38) —
SCHEMBL25448142 0.71 ADH1B (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220168430-A1 THERAPEUTIC METHODS FOR TREATING HEPATITIS B ARBUTUS BIOPHARMA CORPORATION (US) 2022-06-02 — — US disclosed
Send feedback